November 23, 2022 Experience TTX $300 million medium-term note offering The investment-grade notes are due 2052
November 22, 2022 Experience RAPT Therapeutics $75 million follow-on offering The shares are listed on the Nasdaq Global Market
November 18, 2022 Experience Texas Instruments $800 million notes offering We advised Texas Instruments on its investment-grade debt offering
November 9, 2022 Experience Lucid $600 million at-the-market offering and $915 million additional investment The common stock is listed on Nasdaq
November 7, 2022 Experience Equinix $1.5 billion at-the-market offering We advised the company on the SEC-registered at-the-market offering
September 20, 2022 Experience CrowdStrike Holdings acquisition of Reposify We are advising CrowdStrike on the transaction
August 16, 2022 Experience Texas Instruments $700 million notes offering We advised Texas Instruments on its investment-grade debt offering
April 6, 2022 Experience Equinix $1.2 billion green bonds offering We advised Equinix on the investment-grade debt offering
March 25, 2022 Experience AN2 Therapeutics $69 million IPO The shares are listed on the Nasdaq Global Select Market
November 23, 2021 Experience Affirm Holdings $1.725 billion convertible senior notes offering The 0% convertible notes are due 2026